Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint.

The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans to float 10.7 million shares at $24 to $26 apiece, up from $20 to $23 previously, for a total range of $256.8 million to $278.2 million. Its initial IPO filing earlier this month was for a $100 million raise.

Get the full story at our sister site, Drug Delivery Business News